Member Info for Dibs61

....was a buy. Ticked up since. A lot of progress taking place here I think

There is a danger of missing out here but not of over ramping the SP.

Do the research.

He’s right. Most PI’s are blissfully unaware of the humongous opportunity here. And, for most, it will pass them by. Just the fortunate few who got to hear about it by whatever means will make a fortune here.

Actually preferring no RNS today because the constant updates are not doing anything for the SP. Best to let the SP settle and update when the drill has completed.

SP is signalling they are still struggling to get this mine going.

So a string of directors all exercise share options and immediately sell them. 1.7 million directors shares sold collectively! A great vote of confidence in your companies prospects I must say!

Follow the money as they say...

Willem Middlekoop is no mug and he knows what he is doing. He has put a lot of his personal wonga into XTR as part of the CDF investment thus far. Follow the money as they say.

I think on balance the XRF concerns are not a concern. Even in the event that Drill hole 2 doesn't have comparable copper grades to Hole 1 (which lets face it we dont know) - ONE HOLE (in isolation) DOES NOT MAKE A DISCOVERY as GGP also found. Would I even be thinking about selling on that basis? Absolutely not you think I'm going to cut my nose to spite my face!? These kind of opportunities to get in near the bottom don't come up very often and I am not going to miss out here.

The current market valuation is £207m. It is very simple. If, or may I say, WHEN this is approved for use by the FDA the market will not value this at £207m. I don't know exactly what the valuation will become like no one else does either BUT I can safely say you will, in time, have to add another zero onto the valuation number. And then maybe even ANOTHER zero.

We have to remember that the Yanks value pharma and bio, and indeed many other sectors at much higher valuation metrics than our market does. And the US investors will be very very hungry (if they aren't already) for this stock. To them a £207m valuation represents a VERY small cap company. Up to a billion or even two billion to them its a small stock!

So what we have to do here is look at their type of valuations not ours.

It's becoming clear the key to a successful outcome to this JV lies in the Prof's hands. AAZ have stated clearly that they have 'handed it over to the lawyers' to sort out. At first that sounded very positive to me. Then I saw their presentation to the market and.... Oh dear.... that changed everything. Fundamental unresolved issues about operatorship, land acquisition, SPV set up etc.

And I got thinking about it, from the Prof's perspective. This is his 'baby'. This project is the culmination of his lifes work. He's not being difficult in not acquiescing to AAZ wanting to be Operator of the JV. He is thinking that he understands and knows this project best at this stage and he is better qualified to oversee it, at least in the early phases. And it seems to me that this is NOT unreasonable. Sure, once the project advances to the mine development stage you would expect AAZ to take over. That is completely logical. But the Prof is a v good geologist and, at the exploration stage, which they are still in, and he KNOWS the district so well, why would he NOT be in charge at this stage?

Unfortunately for investors this is now clearly blocking progress with the JV and perhaps it is AAZ who need to have a rethink rather than label the Prof as stubborn and intransigent.

Are we still focusing too much on the UK market viz a viz pricing. Its obvious that the price and thus margin will be greater in the US market which IMO (from a purely commercial perspective) we should, and appear to be, concentrating on now.

SNG are under no obligation to serve the UK government first. They can simply go where the greatest return is, and they are.

I think from purely a money making and commercial perspective we should not be bothered by the UK market anymore. Of course it is a crock of s*ite but The US market is far larger and more lucrative. Let’s move on. We have more than enough to cope with potential demand elsewhere in the world.

190.40348 def a BUY according to spread

Someones just taken £300k's worth in a single trade!

This is fantastic news without question. Read the full announcement - it has such exciting possibilities for us - fairly short term.

Still don't think the market has got this at all. Hasn't fully understood the ramifications here!

Sphalerite - so we may have another mineral to add....Zinc

Rise has disappointingly run out of steam

Crazy drop here whats going on? I think its been going down ever since I bought in last week @ 12p! Sorry guys all my fault lol

Jdam - no I'm not. But it's a stock I follow closely. I'm not interested in buying unless they actually get some orders. It's been hot air from the company for too long now. They have to deliver.

PS I note that nobody has been able or willing to counter my points....because they are true.

This is a DISCUSSION board. You can always filter me if you don't like the truth. But its tough I will say it how it is. You prove to me that I'm wrong rather than indulge in juvenile comments like 'go away' or 'trolling'. Pathetic.

I have trawled through yesterdays RNS for a mention of the 'gold standard' Antibody Test - the ABC Rapid Test. The test that ODX were going to be manufacturing and sellingin its millions - not a single mention of it in the RNS, in the trading update, anywhere. Zilch. Yet just two weeks ago there was a specific update re this test on the 26th January quote:

"Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes today's update from Abingdon Health plc (AIM: ABDX) ("Abingdon Health") regarding the AbC-19TM Rapid Test, confirming their expectations for future supply arrangements with the Department of Health and Social Care, the ongoing efforts to obtain regulatory approvals in a total of 27 geographies, and the ongoing work to build data the set(s) around the use-case for the AbC-19TM Rapid Test alongside vaccines."

I then checked Omegas website for information on the ABC Rapid Test and lo and behold it has disappeared completely. I could not find it anywhere. Listen, this was the BIG ONE. The test that was going to massively drive up revenue for ODX and it has been quietly dropped without a single word of explanation. The truth is it has been dropped. Neither the government, scientists, SAGE or anyone connected with have mentioned this Test as part of the vaccine strategy because it ISN'T part of the vaccine strategy.

I have no problem with ODX quickly trying to dig their way out of a massive hole by claiming they will now get a 'Contract' for Antigen Tests but what I would expect as an investor is to be told what has happened rather than just pretend it never happened, cover it up, and suddenly come up with a new strategy. Frankly it is disingenuous and I would be very loath to put my money in a company which does not operate in a clear transparent honest way to investors.